| Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant Melanoma (NCT00978913) | Inge Marie Svane | 2009-09-01 |
| Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast Cancer (NCT01271738) | Emory University | 2009-09-01 |
| Deep Sequencing of the Breast Cancer Transcriptome (NCT01141530) | University of Arkansas | 2009-09-01 |
| Reducing Pain and Disability After Breast Cancer Surgery (NCT01089933) | Ottawa Hospital Research Institute | 2009-09-01 |
| Multicenter Hologic Tomosynthesis Study (NCT00971087) | Hologic, Inc. | 2009-09-01 |
| Axillary Reverse Mapping (NCT01381315) | University of Kansas Medical Center | 2009-09-01 |
| Natriuretic Peptide Concentrations of B-type (BNP) During Anesthesia in Patients Previously Sensitized to Anthracyclines (NCT01754597) | Institut Bergonié | 2009-09-01 |
| S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo (NCT00775645) | SWOG Cancer Research Network | 2009-09-01 |
| The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function (NCT00973557) | Cedars-Sinai Medical Center | 2009-09-01 |
| Data Collection Study of Raw Thermal Images for the Purpose of Developing a Device for Early Detection of Breast Cancer (NCT00821613) | Real Imaging Ltd. | 2009-09-01 |
| Myocet Plus Endoxan for Older Patients With Breast Cancer (NCT01120171) | Hellenic Oncology Research Group | 2009-09-01 |
| Use of Stem Cells in Lymphedema Post Mastectomy (NCT01112189) | Hospital Universitario Dr. Jose E. Gonzalez | 2009-09-01 |
| Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer (NCT00915018) | Puma Biotechnology, Inc. | 2009-08-21 |
| MUC1 Vaccine for Triple-negative Breast Cancer (NCT00986609) | Joseph Baar, MD, PhD | 2009-08-19 |
| A Study of Herceptin (Trastuzumab)and Biomarkers in Patients With HER2-Positive Metastatic Breast Cancer (NCT00885755) | Hoffmann-La Roche | 2009-08-13 |
| Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02 (NCT00963417) | ETOP IBCSG Partners Foundation | 2009-08-03 |
| The Health of Women Study (NCT02334085) | Dr. Susan Love Research Foundation | 2009-08-01 |
| Efficacy and Safety of DLBS1425 in Subjects With Advanced/Metastatic Breast Cancer (NCT01006785) | Dexa Medica Group | 2009-08-01 |
| A Study With Health Educational Material on Health Promotion in Cancer Survivors (NCT00948337) | National Cancer Center, Korea | 2009-08-01 |
| Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer (NCT01232881) | Hoosier Cancer Research Network | 2009-08-01 |
| A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizumab or Trastuzumab, and With Letrozole, in Participants With Locally Recurrent or Metastatic Breast Cancer (NCT00960960) | Genentech, Inc. | 2009-08-01 |
| Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer (NCT01069081) | Fudan University | 2009-08-01 |
| IRB-HSR# 13957: IV Lidocaine for Patients Undergoing Primary Breast Cancer Surgery: (NCT01204242) | University of Virginia | 2009-08-01 |
| Exercise and Breast Cancer Related Lymphedema: Influence of Muscle Group and Sequence on Volume Change in Swollen and Normal Arms (NCT00935714) | Hillel Yaffe Medical Center | 2009-08-01 |
| Early Detection and Intervention for Mild and Moderate Lymphedema in Patients Treated for Breast Cancer (NCT00959985) | Massachusetts General Hospital | 2009-08-01 |
| Efficacy and Safety Study of Trastuzumab, Paclitaxel and Carboplatin on HER2+ Preoperative Breast Cancer (NCT01170143) | Fudan University | 2009-08-01 |
| Bevacizumab and Trastuzumab With Weekly Paclitaxel Followed, After Surgery, by Encapsuled Liposomal Doxorubicin, Cyclophosphamide and Trastuzumab as Adjuvant Treatment After Surgery on Women With Her2+ Breast Cancer (NCT01321775) | Hospital Universitario Madrid Sanchinarro | 2009-08-01 |
| Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast Cancer (NCT01013506) | Vanderbilt-Ingram Cancer Center | 2009-08-01 |
| The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins (NCT01341171) | University of Vermont | 2009-08-01 |
| Risk Education and Assessment for Cancer Heredity (NCT01346761) | University of Utah | 2009-08-01 |
| Limonene Study in Women With Breast Cancer (NCT01046929) | University of Arizona | 2009-08-01 |
| MRI in Predicting Early Response to Chemotherapy in Patients With Locally Advanced Breast Cancer (NCT00978770) | Cancer Clinical Trials Unit, Scotland | 2009-08-01 |
| Broccoli Sprout Extract in Treating Women Who Have Had a Mammogram and Breast Biopsy (NCT00843167) | OHSU Knight Cancer Institute | 2009-08-01 |
| Docetaxel With or Without a Phytochemical in Treating Patients With Breast Cancer (NCT00852332) | Centre Jean Perrin | 2009-08-01 |
| Improved Breast MRI With SWIFT (NCT01156987) | University of Minnesota | 2009-08-01 |
| Study Into the Use of Electrical Impedance Mammography in the Diagnosis and Characterisation of Breast Disease (NCT01217489) | Oxford University Hospitals NHS Trust | 2009-08-01 |
| Effect of a Natural Health Product on Urinary Estrogen Metabolites (NCT01089049) | Nutrasource Pharmaceutical and Nutraceutical Services, Inc. | 2009-08-01 |
| A Study of Whole Brain Radiation Therapy and Capecitabine in Breast Cancer Participants With Newly Diagnosed Brain Metastasis (NCT00977379) | Hoffmann-La Roche | 2009-08-01 |
| 3.0 Tesla Magnetic Resonance Imaging for Breast Cancer Detection in High Risk Women (NCT01409226) | NYU Langone Health | 2009-08-01 |
| Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast Cancer (NCT00880009) | Pfizer | 2009-07-30 |
| The Immune System's Response to Young Women's Breast Cancer (NCT01503190) | University of Colorado, Denver | 2009-07-21 |
| Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca (NCT00934895) | Rutgers, The State University of New Jersey | 2009-07-15 |
| Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer (NCT00878709) | Puma Biotechnology, Inc. | 2009-07-09 |
| Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer (NCT00941759) | Memorial Sloan Kettering Cancer Center | 2009-07-01 |
| Dendritic Cell Based Therapy for Breast Cancer Patients (NCT00935558) | Inge Marie Svane | 2009-07-01 |
| Study to Evaluate the Diagnostic Value of a Combined Molecular Breast Imaging/ Breast Tomosynthesis Modality (NCT01024114) | Mayo Clinic | 2009-07-01 |
| A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer (NCT00938652) | Sanofi | 2009-07-01 |
| The Impact of Obesity and Obesity Treatments on Breast Cancer (NCT00933309) | M.D. Anderson Cancer Center | 2009-07-01 |
| Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer (NCT00971737) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2009-07-01 |
| Promoting Breast Cancer Screening in Non-adherent Women (NCT01332032) | University of Massachusetts, Worcester | 2009-07-01 |
| 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors (NCT00967577) | Weill Medical College of Cornell University | 2009-07-01 |
| Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer (NCT00912444) | Shanghai Jiao Tong University School of Medicine | 2009-07-01 |
| DC Vaccine for Patients With Ductal Carcinoma In Situ (NCT02061332) | Abramson Cancer Center at Penn Medicine | 2009-07-01 |
| Green Tea and Reduction of Breast Cancer Risk (NCT00917735) | University of Minnesota | 2009-07-01 |
| Health Benefits of Expressive Writing: Study One (NCT03546673) | University of Houston | 2009-07-01 |
| Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast (NCT00788112) | University of California, San Francisco | 2009-07-01 |
| Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression (NCT00944047) | University of Kansas Medical Center | 2009-07-01 |
| Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer (NCT00884143) | AstraZeneca | 2009-07-01 |
| Chemotherapy Monitoring With Breast Computed Tomography (CT) (NCT00808041) | Emory University | 2009-07-01 |
| Guided Relaxation Training for the Reduction of Self-Reported Stress in Individuals With Newly Diagnosed Breast Cancer (NCT00945607) | Trinitas Comprehensive Cancer Center | 2009-07-01 |
| Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors (NCT00962494) | Stanford University | 2009-07-01 |
| Doxorubicin Hydrochloride, Cyclophosphamide, Docetaxel, and S-1 Before Surgery in Treating Women With Stage II or Stage III Breast Cancer (NCT00994968) | Yonsei University | 2009-07-01 |
| Comparison of Neo-adjuvant Weekly Paclitaxel With or Without Carboplatin in Early Breast Cancer (NCT00919880) | Tao OUYANG | 2009-07-01 |
| Magnesium Oxide in Treating Hot Flashes in Menopausal Women With Cancer (NCT01008904) | Virginia Commonwealth University | 2009-07-01 |
| Exemestane or Docetaxel-Cytoxan in Low Recurrence Score Cancers (NCT00941330) | Emory University | 2009-07-01 |
| Importance of Magnetic Resonance Imaging (MRI) in Treating Breast Cancer (NCT00948285) | Texas Tech University Health Sciences Center | 2009-07-01 |
| Health SMART (Stress Management and Relaxation Training) (NCT01048528) | Fred Hutchinson Cancer Center | 2009-07-01 |
| A Study to Evaluate the Biological Activity of R1507 in Women With Operable Breast Cancer (NCT00882674) | Hoffmann-La Roche | 2009-07-01 |
| A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer (NCT00929240) | Hoffmann-La Roche | 2009-07-01 |
| Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer (NCT00881361) | Alliance for Clinical Trials in Oncology | 2009-07-01 |
| A Study of Trastuzumab Emtansine (T-DM1) in Combination With Docetaxel, and Potentially Pertuzumab, in Participants With Advanced Breast Cancer (NCT00934856) | Hoffmann-La Roche | 2009-07-01 |
| Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer (NCT01091168) | Pierre Fabre Medicament | 2009-07-01 |
| PEAK PlasmaBlade™ 4.0 Versus Traditional Electrosurgery in Lumpectomy (NCT00960154) | Medtronic Surgical Technologies | 2009-07-01 |
| Flexitouch Lymphedema System in Treating Stage II Lymphedema in Patients With Breast Cancer (NCT01019512) | Abramson Cancer Center at Penn Medicine | 2009-07-01 |
| The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers (NCT01022333) | Women's College Hospital | 2009-07-01 |
| A Randomized Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Line Chemotherapy in Patients With Metastatic Breast Cancer (NCT01200212) | GBG Forschungs GmbH | 2009-07-01 |
| Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy (NCT01185132) | Rocky Mountain Cancer Centers | 2009-07-01 |
| Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer (NCT00788333) | Bristol-Myers Squibb | 2009-07-01 |
| Phase III Trial of High Dose vs. Standard Dose Vit D2 With Docetaxel in Met Breast ca (NCT00944424) | King Faisal Specialist Hospital & Research Center | 2009-07-01 |
| Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients (NCT01814397) | University of Michigan Rogel Cancer Center | 2009-07-01 |
| Study to Evaluate Surgical Excision Margins in Malignant Breast Lumpectomies With the PEAK PlasmaBlade (NCT00972010) | Sarah Blair, M.D. | 2009-07-01 |
| Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients (NCT00929214) | M.D. Anderson Cancer Center | 2009-06-24 |
| Longitudinal Impact of Adjuvant Chemotherapy on Functional Status, Comorbidity and Quality of Life (NCT01030250) | City of Hope Medical Center | 2009-06-11 |
| Xeloda (Capecitabine) and External Beam Radiation (NCT00916578) | M.D. Anderson Cancer Center | 2009-06-05 |
| Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole (NCT00863655) | Novartis Pharmaceuticals | 2009-06-03 |
| Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors (NCT00930527) | Columbia University | 2009-06-01 |
| Patient Activated Controlled Expansion (PACE) Trial (NCT01009008) | AirXpanders, Inc. | 2009-06-01 |
| Enhancing Physical Activity Adherence After Breast Cancer Diagnosis (BEAT Cancer II) (NCT00929617) | University of Alabama at Birmingham | 2009-06-01 |
| Automating Breast Radiation Therapy (RT) (NCT00923871) | University Health Network, Toronto | 2009-06-01 |
| Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast Cancer (NCT01375023) | European Institute of Oncology | 2009-06-01 |
| Vitamin D in Postmenopausal Women at High Risk for Breast Cancer (NCT00859651) | Columbia University | 2009-06-01 |
| Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast Cancer (NCT01150513) | Chinese Academy of Medical Sciences | 2009-06-01 |
| Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer (NCT01712893) | Fudan University | 2009-06-01 |
| Tamoxifen Citrate in Patients With Breast Cancer (NCT00963209) | Centre Hospitalier Universitaire Vaudois | 2009-06-01 |
| Dexrazoxane as a Protective Agent in Anthracycline Treated Breast Cancer (NCT00955890) | Fudan University | 2009-06-01 |
| Joint Pain and Medication Adherence in Postmenopausal Women Receiving Aromatase Inhibitors (NCT00954564) | Vanderbilt University Medical Center | 2009-06-01 |
| Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue (NCT00908791) | Dartmouth-Hitchcock Medical Center | 2009-06-01 |
| Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II) (NCT00900627) | AstraZeneca | 2009-06-01 |
| Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer (NCT00887575) | SCRI Development Innovations, LLC | 2009-06-01 |
| Cisplatin and Paclitaxel With or Without Everolimus in Treating Patients With Stage II or Stage III Breast Cancer (NCT00930930) | Vanderbilt-Ingram Cancer Center | 2009-06-01 |